Last reviewed · How we verify

Danning Tablet — Competitive Intelligence Brief

Danning Tablet (Danning Tablet) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese Medicine (TCM) herbal formulation. Area: Hepatology / Gastroenterology.

marketed Traditional Chinese Medicine (TCM) herbal formulation Hepatology / Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Danning Tablet (Danning Tablet) — Eastern Hepatobiliary Surgery Hospital. Danning Tablet is a traditional Chinese medicine formulation that supports hepatic function and biliary health through multi-component herbal synergy.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Danning Tablet TARGET Danning Tablet Eastern Hepatobiliary Surgery Hospital marketed Traditional Chinese Medicine (TCM) herbal formulation
Jinshuibao Capsule Jinshuibao Capsule Second Xiangya Hospital of Central South University marketed Traditional Chinese Medicine (TCM) herbal formulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese Medicine (TCM) herbal formulation class)

  1. Eastern Hepatobiliary Surgery Hospital · 1 drug in this class
  2. Second Xiangya Hospital of Central South University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Danning Tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/danning-tablet. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: